CareCloud Inc (CCLD)

NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04

$1.80+4.65%

Close 2026-11-04 · 1-day change

Investment OutlookAs of Nov 4, 2026

What could strengthen or challenge CareCloud Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

0.0%

+10% or more+5%0%−5%−10% or less

0.30 → 0.30 EPS · FY ending Dec 31, 2027 · 2 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.

Price, analyst earnings & P/E reference

The EPS and P/E reference is not available for CCLD yet.

Measure / period	Management expectations	Analyst expectations

Management figures unavailable.

Current consensus figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Adjusted EBITDA of $29M to $31M in 2026	Adjusted EBITDA is targeted at $29 to $31 million.	Intact	Adjusted EBITDA falls below $27M in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 2 of 2 supplied quarters. Management reported: “We expect these investments to enhance scalability, improve operational efficiency, and support long-term margin expansion.”” “Q1 2026 adjusted EBITDA was depressed due to transition costs from Medsphere which have largely been eliminated by the end of Q1, so they will have a decreasing impact in future quarters.” Delivery assessment Nov 4, 2026
Increase EPS to $0.20–$0.23 in 2026	A primary condition in CareCloud Inc's published investment case. The stated target is EPS between $0.20 and $0.23.	Intact	EPS falls below $0.10 in FY26	Diluted EPS: $0.00 per share FY2026-Q2; GAAP. Published target: EPS between $0.20 and $0.23. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 20260 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Successful integration of Empower Healthcare acquisition	The company recently acquired Empower Healthcare to support growth.	Intact	Acquisition fails to contribute or causes material losses in FY26	Qualitative: Acquisition completed, no material losses reported CareCloud acquired Empower Healthcare in May 2026. No negative integration signals or material losses reported in recent news. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Achieve revenue of $128M to $132M in 2026	A primary condition in CareCloud Inc's published investment case. The stated target is Revenue between $128M and $132M.	Intact	Revenue falls below $120M in FY26	Revenue: $31.88M FY2026-Q2; GAAP. Published target: Revenue between $128M and $132M. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202631,880,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 2 of 2 supplied quarters. Management reported: “Conference Call Information CareCloud management will host a live conference call today, August 6, 2026, at 8:30 a.m.” “The integration of our Medsphere acquisition impacted our earnings as anticipated this quarter and is now substantially complete, positioning us to deliver improving margins through the balance of 2026.” Delivery assessment Nov 4, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$0.30

$0.29 → $0.30 · observed estimates

FY2027 revenue$0.14B

$0.14B → $0.14B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.29	$140,832,230	3 / 3
2026-07-25	$0.29	$140,832,230	3 / 3
2026-07-26	$0.29	$140,832,230	3 / 3
2026-07-27	$0.29	$140,832,230	3 / 3
2026-07-28	$0.29	$140,832,230	3 / 3
2026-07-29	$0.29	$140,832,230	3 / 3
2026-07-30	$0.29	$140,832,233	3 / 3
2026-07-31	$0.29	$140,832,233	3 / 3
2026-08-01	$0.29	$140,832,230	3 / 3
2026-08-02	$0.29	$140,832,230	3 / 3
2026-08-03	$0.29	$140,832,233	3 / 3
2026-08-04	$0.29	$140,832,233	3 / 3
2026-08-05	$0.29	$140,832,233	3 / 3
2026-08-06	$0.29	$140,832,233	3 / 3
2026-08-07	$0.29	$140,832,233	3 / 3
2026-08-08	$0.29	$140,832,233	3 / 3
2026-08-09	$0.29	$140,832,233	3 / 3
2026-08-10	$0.29	$140,832,233	3 / 3
2026-08-11	$0.30	$141,180,500	3 / 3
2026-08-12	$0.29	$140,832,233	3 / 3
2026-08-13	$0.29	$140,832,233	3 / 3
2026-08-14	$0.29	$140,832,233	3 / 3
2026-08-15	$0.29	$140,832,233	3 / 3
2026-08-16	$0.29	$140,832,233	3 / 3
2026-08-17	$0.29	$140,832,233	3 / 3
2026-08-18	$0.29	$140,832,233	3 / 3
2026-08-19	$0.29	$140,832,233	3 / 3
2026-08-20	$0.30	$141,179,667	3 / 3
2026-08-21	$0.30	$141,179,667	3 / 3
2026-08-22	$0.30	$141,179,667	3 / 3
2026-08-23	$0.30	$141,179,667	3 / 3
2026-08-24	$0.30	$141,179,667	3 / 3
2026-08-25	$0.30	$141,179,667	3 / 3
2026-08-26	$0.30	$141,179,667	3 / 3
2026-08-27	$0.30	$141,179,667	3 / 3
2026-08-28	$0.30	$141,179,667	3 / 3
2026-08-29	$0.30	$141,179,667	3 / 3
2026-08-30	$0.30	$141,179,667	3 / 3
2026-08-31	$0.30	$141,179,667	3 / 3
2026-09-01	$0.30	$141,179,667	3 / 3
2026-09-02	$0.30	$141,179,667	3 / 3
2026-09-03	$0.30	$141,179,667	3 / 3
2026-09-04	$0.30	$141,179,667	3 / 3
2026-09-05	$0.30	$141,179,667	3 / 3
2026-09-06	$0.30	$141,179,667	3 / 3
2026-09-07	$0.30	$141,179,667	3 / 3
2026-09-08	$0.30	$141,179,667	3 / 3
2026-09-09	$0.30	$141,179,667	3 / 3
2026-09-10	$0.30	$141,179,667	3 / 3
2026-09-11	$0.30	$141,179,667	3 / 3
2026-09-12	$0.30	$141,179,667	3 / 3
2026-09-13	$0.30	$141,179,667	3 / 3
2026-09-14	$0.30	$141,179,667	3 / 3
2026-09-15	$0.30	$141,179,667	3 / 3
2026-09-16	$0.30	$141,179,667	3 / 3
2026-09-17	$0.30	$142,862,000	2 / 2
2026-09-18	$0.30	$142,862,000	2 / 2
2026-09-19	$0.30	$142,862,000	2 / 2
2026-09-20	$0.30	$142,862,000	2 / 2
2026-09-21	$0.30	$142,862,000	2 / 2
2026-09-22	$0.30	$142,862,000	2 / 2
2026-09-23	$0.30	$142,862,000	2 / 2
2026-09-24	$0.30	$142,862,000	2 / 2
2026-09-25	$0.30	$142,862,000	2 / 2
2026-09-26	$0.30	$142,862,000	2 / 2
2026-09-27	$0.30	$142,862,000	2 / 2
2026-09-28	$0.30	$142,862,000	2 / 2
2026-09-29	$0.30	$142,862,000	2 / 2
2026-09-30	$0.30	$142,862,000	2 / 2
2026-10-01	$0.30	$142,862,000	2 / 2
2026-10-02	$0.30	$142,862,000	2 / 2
2026-10-03	$0.30	$142,862,000	2 / 2
2026-10-04	$0.30	$142,862,000	2 / 2
2026-10-05	$0.30	$142,862,000	2 / 2
2026-10-06	$0.30	$142,862,000	2 / 2
2026-10-07	$0.30	$142,862,000	2 / 2
2026-10-08	$0.30	$142,862,000	2 / 2
2026-10-09	$0.30	$142,862,000	2 / 2
2026-10-10	$0.30	$142,862,000	2 / 2
2026-10-11	$0.30	$142,862,000	2 / 2
2026-10-12	$0.30	$142,862,000	2 / 2
2026-10-13	$0.30	$142,862,000	2 / 2
2026-10-14	$0.30	$142,862,000	2 / 2
2026-10-15	$0.30	$142,862,000	2 / 2
2026-10-16	$0.30	$142,862,000	2 / 2
2026-10-17	$0.30	$142,862,000	2 / 2
2026-10-18	$0.30	$142,862,000	2 / 2
2026-10-19	$0.30	$142,862,000	2 / 2
2026-10-20	$0.30	$142,862,000	2 / 2
2026-10-21	$0.30	$142,862,000	2 / 2
2026-10-22	$0.30	$142,862,000	2 / 2
2026-10-23	$0.30	$142,862,000	2 / 2
2026-10-24	$0.30	$142,862,000	2 / 2
2026-10-25	$0.30	$142,862,000	2 / 2
2026-10-26	$0.30	$142,862,000	2 / 2
2026-10-27	$0.30	$142,862,000	2 / 2
2026-10-28	$0.30	$142,862,000	2 / 2
2026-10-29	$0.30	$142,862,000	2 / 2
2026-10-30	$0.30	$142,862,000	2 / 2
2026-10-31	$0.30	$142,862,000	2 / 2
2026-11-01	$0.30	$142,862,000	2 / 2
2026-11-02	$0.30	$142,862,000	2 / 2
2026-11-03	$0.30	$142,862,000	2 / 2
2026-11-04	$0.30	$142,862,000	2 / 2

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-06-01	2	1
2026-07-01	2	1
2026-08-01	2	1
2026-09-01	2	1
2026-10-01	2	1
2026-11-01	2	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Oct 6–Nov 4 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Adjusted EBITDA of $29M to $31M in 2026Direct metric needs a verified mapping
Increase EPS to $0.20–$0.23 in 2026Diluted EPS: $0.00 per share
Achieve revenue of $128M to $132M in 2026Revenue: $31.88M

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.9%Typical daily move · historical

Downside history

-55.1%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

CareCloud Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 31, 2026

What kind of bet this is

CCLD is a higher-risk growth business with recent financial performance in the top half of its industry. The long-term thesis is intact, though a recent earnings miss and CEO transition add uncertainty.

What's priced into CareCloud Inc

The valuation evidence is mixed: CCLD is described as cheap versus peers, while another measure shows a premium to peers. The expectations gap is negative, which suggests market expectations may be cautious; the evidence does not point to a clear valuation cushion.

What the fundamentals likely do

Near term, first-half 2026 revenue rose 15% from the prior year, and management reaffirmed its revenue and EPS guidance. Adjusted EBITDA was slightly lower year over year, and actual GAAP EPS was near zero or negative in the first two quarters, so delivery on the full-year targets remains important. A prior earnings miss and the company’s run of consecutive misses add risk despite the reaffirmed guidance.

What CareCloud Inc hinges on

The multi-year view hinges on whether revenue growth translates into improving profitability and whether management delivers its 2026 targets. A guidance cut would be a meaningful negative, while continued strength among healthcare sector bellwethers could support the sector backdrop. Weakening job growth could weigh on cyclical healthcare names, including CCLD.